On 2 December 2025, Inna Zhuranskaya and Judy Kingswolf-Yamakawa attended the AI Breakfast Club in London, a key event for AI founders, innovators, and enthusiasts. This special edition of the breakfast focused on AI’s transformative potential in health and biotechnology, bringing together an exceptional panel of industry leaders. Speakers included Diana Roettger, Investment Principal at LifeArc Investments, Rebecca Wray, Senior Director at AstraZeneca, Dr. Chris Bakal, Founder of Sentinal 4d, and Katie Lockwood, Partner at Twin Path Ventures. The discussions explored how AI is accelerating drug discovery, improving diagnostics, and reshaping patient care. Attendees gained forward-thinking insights into the future of healthcare and biotech, making it a valuable opportunity for networking and discovering the latest trends in AI innovation.